Incyte, a Delaware-founded global biopharmaceutical company with a robust portfolio of treatments across oncology and inflammation and autoimmunity, has chosen downtown Wilmington, Delaware, for an expansion. Incyte today announced it has purchased the Bracebridge I and Bracebridge III buildings at King and French streets in downtown Wilmington. The structures were built in the mid-1990s for…
